<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Although <z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">hyperinsulinaemia</z:e> in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in states of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> is a risk factor for atherosclerotic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e>, underlying mechanisms are poorly understood </plain></SENT>
<SENT sid="1" pm="."><plain>We tested the hypothesis that insulin increases monocyte-endothelial interactions, which are implicated in <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We treated human umbilical vein endothelial cells with insulin (10(-10) to 10(-7) mol/l) for 0 to 24 h </plain></SENT>
<SENT sid="3" pm="."><plain>To dissect potentially implicated signal transduction pathways, we treated endothelial cells with known pharmacological inhibitors of two distinct insulin signalling pathways: the phosphatidylinositol-3'-kinase (PI3'-kinase) inhibitor <z:chebi fb="0" ids="52289">wortmannin</z:chebi> (3 x 10(-8) to 10(-6) mol/l), involved in insulin-induced endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase stimulation, and the p38 <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein (p38MAP) kinase inhibitor SB-203580 (10(-7) to 2 x 10(-6) mol/l) </plain></SENT>
<SENT sid="4" pm="."><plain>We measured <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule expression by cell surface enzyme immunoassays and U937 monocytoid cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> in rotational <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> assays </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: At pathophysiological concentrations (10(-9) to 10(-7) mol/l), insulin concentration-dependently induced vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule (VCAM)-1 (average increase: 1.8-fold) peaking at 16 h </plain></SENT>
<SENT sid="6" pm="."><plain>By contrast, the expression of intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 and E-selectin were unchanged </plain></SENT>
<SENT sid="7" pm="."><plain>The effect on VCAM-1 was paralleled by increased U937 cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In the absence of cytotoxicity, <z:chebi fb="0" ids="52289">wortmannin</z:chebi> significantly potentiated the effect of insulin alone on VCAM-1 surface expression and monocytoid cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, whereas SB-203580 (10(-6) mol/l) completely abolished such effects </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/INTERPRETATION: These observations indicate that insulin promotes VCAM-1 expression in endothelial cells through a p38MAP-kinase pathway, amplified by the PI3'-kinase blockage </plain></SENT>
<SENT sid="10" pm="."><plain>This could contribute to explaining the increased <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> occurring in subjects with <z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">hyperinsulinaemia</z:e>, or in states of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, which feature a defective PI3'-kinase pathway </plain></SENT>
</text></document>